Press Release | Frontier Medicines - Part 5

Frontier Medicines to Present at Two Upcoming Investor Conferences

August 25, 2025/in 2021, Press Release/by eallison

May 18, 2021

Frontier Medicines Appoints Seasoned Executive Gregory Chow as Chief Financial Officer

August 25, 2025/in 2021, Press Release/by eallison

March 31, 2021

Frontier Medicines Appoints Drug Development Expert David M. Goldstein, Ph.D., to its Board of Directors

August 22, 2025/in 2020, Press Release/by eallison

March 30, 2021

Frontier Medicines to Present at the 39th Annual J.P. Morgan Healthcare Conference

August 22, 2025/in 2021, Press Release/by eallison

January 8, 2021

Frontier Medicines and AbbVie Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets

August 22, 2025/in 2020, Press Release/by eallison

December 2, 2020

Chemical & Engineering News Names Frontier Medicines One of Its 10 Chemistry Start-Ups to Watch

August 22, 2025/in 2019, Press Release/by eallison

November 11, 2019

FierceBiotech Names Frontier Medicines One of Its “Fierce 15” Biotech Companies of 2019

August 22, 2025/in 2019, Press Release/by eallison

September 23, 2019

Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies

August 22, 2025/in 2019, Press Release/by eallison

July 31, 2019

Frontier Medicines Launches with $67 Million to Develop Novel Medicines that Drug the “Undruggable” Targets Driving Human Disease

August 22, 2025/in 2019, Press Release/by eallison

June 25, 2019